rs763216519

Variant summary

Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP4

This summary comes from the ClinGen Evidence Repository: This variant, c.876C>G (p.Tyr292Ter), is a nonsense variant that is predicted to result in nonsense mediated decay and lack of gene product. Therefore, PVS1 can be applied. Functional studies, in which the variant was expressed in COS cells revealed no GAA activity in the cells or medium. However, a faint band representing GAA protein was detectable on Western blot (PMID 31510962). As the experiment was done in an in vitro expression system, it is unclear whether any gene product would be made in vivo. This variant was absent in gnomAD v2.1.1, meeting PM2. Two patients with infantile onset Pompe disease from Thailand have been reported (PMID 31510962). The residual GAA activity was provided for one of them, meeting PP4. This patient is compound heterozygous for the variant and c.1003G>A (p.Gly335Arg). The in trans data from this patient was used in the assessment of p.Gly335Arg and is not included here in order to avoid circular logic. The other patient is homozygous, and both parents were confirmed to be carriers, but the residual GAA activity is not available, and this data will not be included. Therefore, PM3 is currently not met. There is a ClinVar entry for this variant (Variation ID: 637958, 0 star review status) with one submitter (an author of this paper) classifying the variant as pathogenic. In summary, this variant meets the criteria to be classified as pathogenic for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: PVS1, PM2, PP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA401363871/MONDO:0009290/010

Frequency

Genomes: not found (cov: 33)

Consequence

GAA
NM_000152.5 stop_gained

Scores

2
1
4

Clinical Significance

Pathogenic reviewed by expert panel P:2

Conservation

PhyloP100: -2.90
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 11 ACMG points.

PVS1
For more information check the summary or visit ClinGen Evidence Repository.
PM2
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GAANM_000152.5 linkuse as main transcriptc.876C>G p.Tyr292Ter stop_gained 5/20 ENST00000302262.8 NP_000143.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GAAENST00000302262.8 linkuse as main transcriptc.876C>G p.Tyr292Ter stop_gained 5/201 NM_000152.5 ENSP00000305692 P1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
57
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Glycogen storage disease, type II Pathogenic:2
Pathogenic, no assertion criteria providedclinical testing;in vitroDepartment of Pediatrics, Division of Medical Genetics, Faculty of Medicine Ramathibodi Hospital, Mahidol UniversityJul 10, 2019The c.876C>G creates a premature protein product p.Y292* resulting from early termination of protein synthesis. This variant has not been reported in the literature in individuals with GAA-related disease. The c.876C>G (p.Y292*) located at N-terminal of beta-sheet domain, is predicted to eliminate most of the enzyme, including the catalytic domain. In vitro expression analysis of c.876C>G (p.Y292*) indicates that this mutation lead to undetectable GAA activity in both cell lysate and culture medium and prohibited secretion of the precursor form completely. We interpret this variant has been classified as Pathogenic. -
Pathogenic, reviewed by expert panelcurationClinGen Lysosomal Storage Disorder Variant Curation Expert PanelOct 05, 2020This variant, c.876C>G (p.Tyr292Ter), is a nonsense variant that is predicted to result in nonsense mediated decay and lack of gene product. Therefore, PVS1 can be applied. Functional studies, in which the variant was expressed in COS cells revealed no GAA activity in the cells or medium. However, a faint band representing GAA protein was detectable on Western blot (PMID 31510962). As the experiment was done in an in vitro expression system, it is unclear whether any gene product would be made in vivo. This variant was absent in gnomAD v2.1.1, meeting PM2. Two patients with infantile onset Pompe disease from Thailand have been reported (PMID 31510962). The residual GAA activity was provided for one of them, meeting PP4. This patient is compound heterozygous for the variant and c.1003G>A (p.Gly335Arg). The in trans data from this patient was used in the assessment of p.Gly335Arg and is not included here in order to avoid circular logic. The other patient is homozygous, and both parents were confirmed to be carriers, but the residual GAA activity is not available, and this data will not be included. Therefore, PM3 is currently not met. There is a ClinVar entry for this variant (Variation ID: 637958, 0 star review status) with one submitter (an author of this paper) classifying the variant as pathogenic. In summary, this variant meets the criteria to be classified as pathogenic for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: PVS1, PM2, PP4. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.29
CADD
Pathogenic
35
DANN
Uncertain
0.98
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.19
N
MutationTaster
Benign
1.0
A;A
Vest4
0.78
GERP RS
-6.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.23
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.23
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs763216519; hg19: chr17-78081616; API